carbamates has been researched along with phenylpropanolamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Graw, W; Kadar, V; McIlreath, FJ | 1 |
Phinney, KW; Sander, LC; Wise, SA | 1 |
Ballarín, M; Balsa, D; Cabellos, J; Davalillo, S; Fernández, A; Lagunas, C; Pérez-Del-Pulgar, S; Salcedo, C | 1 |
Cochran, JH; Emmerton, KK; Haelsig, KT; Jeffrey, SC; Kolakowski, RV; Leiske, CI; Lyon, RP; Miyamoto, JB; Senter, PD | 1 |
4 other study(ies) available for carbamates and phenylpropanolamine
Article | Year |
---|---|
A method for evaluating drug action on the cardiovascular system.
Topics: Amphetamine; Animals; Blood Pressure; Blood Pressure Determination; Carbamates; Ephedrine; Guanethidine; Mecamylamine; Phenylephrine; Phenylpropanolamine; Rats; Sympatholytics | 1965 |
Coupled achiral/chiral column techniques in subcritical fluid chromatography for the separation of chiral and nonchiral compounds.
Topics: Adrenergic beta-Antagonists; Amylose; Benzodiazepines; Carbamates; Cellulose; Chromatography, Liquid; Drug Combinations; Expectorants; Guaifenesin; Nasal Decongestants; Phenylcarbamates; Phenylpropanolamine; Stereoisomerism | 1998 |
In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
Topics: Animals; Atrial Function; Benzhydryl Compounds; Benzofurans; Carbamates; Cresols; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder | 2009 |
The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug Conjugates.
Topics: Aminobenzoates; Animals; Antineoplastic Agents, Immunological; Carbamates; Cell Line, Tumor; Drug Delivery Systems; Hodgkin Disease; Humans; Immunoconjugates; Mice; Neoplasms; Oligopeptides; Phenylpropanolamine; Tubulin Modulators | 2016 |